Skip to main content

Advertisement

SpringerLink
Log in

Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

Toxoplasmosis is one of the most common parasitic infections worldwide. An effective vaccine against human and animal toxoplasmosis is still needed to control this parasitosis. The polymorphic rhoptry proteins, ROP5 and ROP18, secreted by Toxoplasma gondii during the invasion of the host cell have been recently considered as promising vaccine antigens, as they appear to be the major determinants of T. gondii virulence in mice. The goal of this study was to evaluate their immunogenic and immunoprotective activity after their administration (separately or both recombinant proteins together) with the poly I:C as an adjuvant. Immunization of BALB/c and C3H/HeOuJ mice generated both cellular and humoral specific immune responses with some predominance of IgG1 antibodies. The spleen cells derived from vaccinated animals reacted to the parasite’s native antigens. Furthermore, the immunization led to a partial protection against acute and chronic toxoplasmosis. These findings confirm the previous assumptions about ROP5 and ROP18 antigens as valuable components of a subunit vaccine against toxoplasmosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Abdollahi SH, Ayoobi F, Khorramdelazad H, Hassanshahi G, Ahmadabadi BN, Rezayati M, Ravary A, Shamsizadeh A, Arababadi MK (2013) Interleukin-10 serum levels after vaccination with in vivo prepared Toxoplasma gondii excreted/secreted antigens. Oman Med J 28:112–5

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Araujo FG, Williams DM, Grumet FC, Remington JS (1976) Strain-dependent differences in murine susceptibility to toxoplasma. Infect Immun 13:1528–1530

    PubMed Central  CAS  PubMed  Google Scholar 

  • Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K, Sibley LD (2011) Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci U S A 108:9631–9636

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Blader IJ, Saeij JP (2009) Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence. APMIS 117:458–476

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Borges O, Borchard G, de Sousa A, Junginger HE, Cordeiro-da-Silva A (2007) Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers. Int J Pharm 337:254–264

    Article  CAS  PubMed  Google Scholar 

  • Chen J, Li ZY, Petersen E, Huang SY, Zhou DH, Zhu XQ (2015) DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice. Expert Rev Vaccines 14:617–624

    Article  CAS  PubMed  Google Scholar 

  • Denkers EY, Gazzinelli RT (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11:569–588

    PubMed Central  CAS  PubMed  Google Scholar 

  • Dlugonska H (2008) Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis. J Biomed Biotechnol 2008:632424

    Article  PubMed Central  PubMed  Google Scholar 

  • Dubey JP (2009) History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol 39:877–882

    Article  CAS  PubMed  Google Scholar 

  • Dupont CD, Christian DA, Hunter CA (2012) Immune response and immunopathology during toxoplasmosis. Semin Immunopathol 34:793–813

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Długonska H (2009) Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Exp Parasitol 123:81–89

    Article  CAS  PubMed  Google Scholar 

  • Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Grzybowski M, Dlugonska H (2011) Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Vaccine 29:821–830

    Article  CAS  PubMed  Google Scholar 

  • Dziadek B, Gatkowska J, Grzybowski M, Dziadek J, Dzitko K, Dlugonska H (2012) Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice. Exp Parasitol 131:133–138

    Article  CAS  PubMed  Google Scholar 

  • El Hajj H, Demey E, Poncet J, Lebrun M, Wu B, Galéotti N, Fourmaux MN, Mercereau-Puijalon O, Vial H, Labesse G, Dubremetz JF (2006) The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling. Proteomics 6:5773–5784

    Article  PubMed  Google Scholar 

  • El Hajj H, Lebrun M, Arold ST, Vial H, Labesse G, Dubremetz JF (2007) ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii. PLoS Pathog 3, e14

    Article  PubMed Central  PubMed  Google Scholar 

  • Etheridge RD, Alaganan A, Tang K, Lou HJ, Turk BE, Sibley LD (2014) The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice. Cell Host Microbe 15:537–50

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fentress SJ, Sibley LD (2011) The secreted kinase ROP18 defends Toxoplasma’s border. Bioessays 33:693–700

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fentress SJ, Behnke MS, Dunay IR, Mashayekhi M, Rommereim LM, Fox BA, Bzik DJ, Taylor GA, Turk BE, Lichti CF, Townsend RR, Qiu W, Hui R, Beatty WL, Sibley LD (2010) Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. Cell Host Microbe 8:484–495

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Filisetti D, Candolfi E (2004) Immune response to Toxoplasma gondii. Ann Ist Super Sanita 40:71–80

    CAS  PubMed  Google Scholar 

  • Gatkowska J, Hiszczynska-Sawicka E, Kur J, Holec L, Długonska H (2006) Toxoplasma gondii: an evaluation of diagnostic value of recombinant antigens in a murine model. Exp Parasitol 114:220–227

    Article  CAS  PubMed  Google Scholar 

  • Grzybowski MM, Dziadek B, Dziadek J, Gatkowska J, Dzitko K, Długońska H (2015) Toxoplasma gondii: cloning. expression and immunoreactivity of recombinant ROP5 and ROP18 antigens. Exp Parasitol 150:1–6

    Article  CAS  PubMed  Google Scholar 

  • Hiszczyńska-Sawicka E, Gatkowska JM, Grzybowski MM, Długońska H (2014) Veterinary vaccines against toxoplasmosis. Parasitology 141:1365–1378

    Article  PubMed  Google Scholar 

  • Innes EA, Bartley PM, Maley S, Katzer F, Buxton D (2009) Veterinary vaccines against Toxoplasma gondii. Mem Inst Oswaldo Cruz 104:246–51

    Article  CAS  PubMed  Google Scholar 

  • Jensen KD, Camejo A, Melo MB, Cordeiro C, Julien L, Grotenbreg GM, Frickel EM, Ploegh HL, Young L, Saeij JP (2015) Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination. MBio 6, e02280

    Article  PubMed Central  PubMed  Google Scholar 

  • Jongert E, Roberts CW, Gargano N, Förster-Waldl E, Petersen E (2009) Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz 104:252–66

    Article  CAS  PubMed  Google Scholar 

  • Khan A, Taylor S, Ajioka JW, Rosenthal BM, Sibley LD (2009) Selection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in mice. PLoS Genet 5, e1000404

    Article  PubMed Central  PubMed  Google Scholar 

  • Li XZ, Wang XH, Xia LJ, Weng YB, Hernandez JA, Tu LQ, Li LT, Li SJ, Yuan ZG (2015) Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice. BMC Infect Dis 15:114

    Article  PubMed Central  PubMed  Google Scholar 

  • Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965–1976

    Article  CAS  PubMed  Google Scholar 

  • Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173

    Article  CAS  PubMed  Google Scholar 

  • Niedelman W, Gold DA, Rosowski EE, Sprokholt JK, Lim D, Farid Arenas A, Melo MB, Spooner E, Yaffe MB, Saeij JP (2012) The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog 8, e1002784

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Pifer R, Yarovinsky F (2011) Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol 27:388–93

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Qiu W, Wernimont A, Tang K, Taylor S, Lunin V, Schapira M, Fentress S, Hui R, Sibley LD (2009) Novel structural and regulatory features of rhoptry secretory kinases in Toxoplasma gondii. EMBO J 28:969–79

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Qu D, Han J, Du A (2013a) Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re. Exp Parasitol 135:234–239

    Article  CAS  PubMed  Google Scholar 

  • Qu D, Han J, Du A (2013b) Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice. Parasitol Res 112:2593–2599

    Article  PubMed  Google Scholar 

  • Reese ML, Boyle JP (2012) Virulence without catalysis: how can a pseudokinase affect host cell signaling? Trends Parasitol 28:53–57

    Article  CAS  PubMed  Google Scholar 

  • Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP (2011) Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci U S A 108:9625–9630

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Reese ML, Shah N, Boothroyd JC (2014) The Toxoplasma pseudokinase ROP5 is an allosteric inhibitor of the immunity-related GTPases. J Biol Chem 289:27849–27858

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Robert-Gangneux F, Dardé ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25:264–296

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Roberts CW, McLeody R, Henriquez FL, Alexander J (2014) Vaccination against toxoplasmosis: current status and future prospects. In: Weiss LM, Kim K (ed) Toxoplasma gondii. The model apicomplexan – perspectives and methods, 2nd edn. Elsevier, pp 995–1045

  • Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, Ajioka JW, Boothroyd JC (2006) Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314:1780–1783

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Salem ML, Kadima AN, Cole DJ, Gillanders WE (2005) Defining the antigen-specific T-cell response to vaccination and poly (I: C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity. J Immunother 28:220–228

    Article  CAS  PubMed  Google Scholar 

  • Sayles PC, Gibson GW, Johnson LL (2000) B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun 68:1026–1033

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Selleck EM, Fentress SJ, Beatty WL, Degrandi D, Pfeffer K, Virgin HW 4th, Macmicking JD, Sibley LD (2013) Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii. PLoS Pathog 9, e1003320

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sheffield P, Garrard S, Derewenda Z (1999) Overcoming expression and purification problems of RhoGDI using a family of “parallel” expression vectors. Protein Expr Purif 15:34–39

  • Steinfeldt T, Könen-Waisman S, Tong L, Pawlowski N, Lamkemeyer T, Sibley LD, Hunn JP, Howard JC (2010) Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol 8, e1000576

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sturge CR, Yarovinsky F (2014) Complex immune cell interplay in the gamma interferon response during Toxoplasma gondii infection. Infect Immun 82:3090–3097

    Article  PubMed Central  PubMed  Google Scholar 

  • Sullivan WJ Jr, Smith AT, Joyce BR (2009) Understanding mechanisms and the role of differentiation in pathogenesis of Toxoplasma gondii: a review. Mem Inst Oswaldo Cruz 104:155–61

    Article  PubMed Central  CAS  Google Scholar 

  • Suzuki Y, Orellana MA, Schreiber RD, Remington JS (1988) Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240:516–518

    Article  CAS  PubMed  Google Scholar 

  • Taylor S, Barragan A, Su C, Fux B, Fentress SJ, Tang K, Beatty WL, Hajj HE, Jerome M, Behnke MS, White M, Wootton JC, Sibley LD (2006) A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314:1776–1780

    Article  CAS  PubMed  Google Scholar 

  • Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30:1217–58

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Vercammen M, Scorza T, Huygen K, De Braekeleer J, Diet R, Jacobs D, Saman E, Verschueren H (2000) DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 68:38–45

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Verma R, Khanna P (2013) Development of Toxoplasma gondii vaccine: a global challenge. Hum Vaccin Immunother 9:291–293

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165:63–74

    Article  CAS  PubMed  Google Scholar 

  • Yuan ZG, Zhang XX, Lin RQ, Petersen E, He S, Yu M, He XH, Zhou DH, He Y, Li HX, Liao M, Zhu XQ (2011) Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 29:6614–6619

    Article  CAS  PubMed  Google Scholar 

  • Zhang NZ, Chen J, Wang M, Petersen E, Zhu XQ (2013) Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Rev Vaccines 12:1287–1299

    Article  CAS  PubMed  Google Scholar 

  • Zheng B, Lu S, Tong Q, Kong Q, Lou D (2013) The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine 31:4578–84

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was funded by the National Science Centre (Poland) on the basis of the decision DEC-2011/03/N/NZ6/04655.

Author information

Authors and Affiliations

  1. Department of Immunoparasitology, Faculty of Biology and Environmental Protection, University of Łódź, Łódź, Poland

    Marcin M. Grzybowski, Bożena Dziadek, Justyna M. Gatkowska, Katarzyna Dzitko & Henryka Długońska

Authors
  1. Marcin M. Grzybowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bożena Dziadek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Justyna M. Gatkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katarzyna Dzitko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Henryka Długońska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcin M. Grzybowski.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grzybowski, M.M., Dziadek, B., Gatkowska, J.M. et al. Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins. Parasitol Res 114, 4553–4563 (2015). https://doi.org/10.1007/s00436-015-4701-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-015-4701-y

Keywords

Search

Navigation